Suchergebnisse - "Langer, Jakob"

PubPharm (3)

1

Long-term cost-effectiveness analysis shows that IDegLira is associated with improved outcomes and lower costs compared with insulin glargine U100 plus insulin aspart in the US

enthalten in: Journal of medical economics | 2018

von Dempsey, M. | Mocarski, M. | Langer, J. | +1

2

Predictors of glycemic control and diabetes-related costs among type 2 diabetes patients initiating therapy with liraglutide in the United States

enthalten in: Journal of medical economics | 2016

von Durden, E. | Lenhart, G. | Lopez-Gonzalez, L. | +2

3

Long-term clinical and economic outcomes associated with liraglutide versus sitagliptin therapy when added to metformin in the treatment of type 2 diabetes : a CORE Diabetes Model analysis

enthalten in: Journal of medical economics | 2012

von Lee, W. | Samyshkin, Y. | Langer, J. | +1

1
[1]